Human endocan recombinant 20 kDa (50 µg)

Purified human Endocan, non-glycosylated.
Ref : LIP-1002-50U
Sales price 560,00 €


This reference ( LIP-1002-50U) is only intended for research (RUO / research use only). And not for diagnostic or therapeutic uses.



Mutation of the single glycosylation Site (S137A) prevents the formation of the glycan chain endocan.

This mutation generates a non-glycosylated 20 kDa protein corresponding to the body of the molecule.

Key identified biological activities :

  • Anti-tumor, 
  • Pro-inflammatory.


  • Recombinant human S137A Endocan expressed by a human cell line type HEK293
  • Produced in bioreactor in fetal calf serum free medium
  • Purified by ion exchange and  immunoaffinity chromatographies
  • PM: 20kDa Western blot
  • Format: 50 µg
  • Purity: > 90% polyacrylamide gel revealed by silver nitrate
  • Storage at -80 ° C in phosphate buffer without preservatives
  • Applications: bioassays

Complementary products

  • Endomark® H1 : LIDM-1201
  • Anticorps anti-endocan humain (N-Ter) MEP21 100 µg : LIA-0902
  • Anticorps anti-endocan humain (C-Ter) MEP14 100 µg : LIA-1001
  • Do It Yourself ELISA Kit H1 (Endocan humain) : LIK-1101


This reference can be also ordered in superior quantity (bulk). Do not hesitate to contact us for any questions and/or quotation request at This email address is being protected from spambots. You need JavaScript enabled to view it..